Introduction

Histone deacetylase 8 (HDAC8) is an enzyme that plays a role in controlling gene expression. Specifically, HDAC8 removes an acetyl group off of the ε-amino-Lys 382 of Histone 4's N-terminal core.^[1] Histones consist of eight monomers to form an octomer complex. Each histone has a positive charge which allows interaction with negatively-charged DNA. This prevents transcription factors from accessing DNA, thus, decreasing gene expression. Chromatin remodeling by histone acetylation and/or deacetylation is an example of epigenetic regulation. Histone Acetylase 1 (HAT1) catalyzes the addition of an acetyl group onto a histone. The lack of charge on the acetyl group weakens the interaction between DNA and histones which allows transcription factors to access the DNA to increase gene expression. HDAC8 reverses this reaction by catalyzing the removal of these acetyl groups from the Lys to reclaim the positive charge of the histone. This allows the histone to interact with the negative charge on the DNA. As a result, DNA binds more tightly to the histone protein, repressing transcription and gene expression.

HDAC Enzymes and Homology

There are four major classes of HDAC proteins (I,II, III, and IV). Other than the Class III “sirtuins” that utilize a NAD⁺ cofactor-dependent mechanism, all other HDAC classes use Zn²⁺-assisted catalysis through mechanisms (Figure 3) reminiscent of a typical serine protease.^[2] While Classes I, II, and IV do have some major distinctions such as size of the protein, in general, they share homology at the catalytic site. HDAC 8 is classified as a Class I HDAC alongside HDACs 1-3. In fact, within Class I HDACs, there are many invariant residues involved in the catalytic site (such as His-Asp dyads), Zn-binding, and ligand binding pocket (such as Asp101) (Figure 1). ^[1]

Figure 1: Weblogo representation comparing conservation of residues (143-182 in HDAC8) to homologous sequences in all class I HDACs. Nearly all active site, zinc binding, and binding pocket residues are conserved across all class I HDACs.

HDAC8 Structure

The HDAC8 comprises a single α/β domain that is composed of an one with eight parallel β-strands sandwiched between 13 . The HDAC8 consists of 377 amino acids, half of which are contained in the secondary structure elements and the other half are contained in loops that link the various elements of the secondary structure. The residues forming active site and catalytic machinery of the enzyme is found in the loops from the C-terminal ends of the strands of the core β-sheet. ^[3]

Zinc Ion

The pentacoordinated Zn²⁺ ion involved in the metalloenzyme catalysis is tethered to the protein through interactions with . This positions the metal ion to favorably interact with the catalytic water and acetylated lysine substrate. ^[1] The zinc ion lowers the pKa of a water proton that makes the water more nucleophilic. Additionally, the zinc likely also facilitates the deacetylation process by reducing the entropy of the reaction by binding both the nucleophile and the substrate, polarizing the carbonyl of the acetyl-lysine and stabilizing the transition state.^[3]

Key Residues

The of HDAC8 is composed of 2 catalytic dyads: , which activate the catalytic water nucleophile (Figure 2). A Tyr306, through mutation to Phe in the pdb file 2v5w (modeled in the overall view) was observed to render the protein mostly inactive. Thus, it has been hypothesized that the this residue is critical for stabilization of the transition state with the Zn²⁺ ion. This mutation allowed the determination of the crystal structure of HDAC8 in complex with the ligand. ^[1]

Figure 2: HDAC8 utilizes a "catalytic dyad" of Asp and His. The His assists in the coordination of the H₂O nucleophile. This mechanism is reminiscent to the catalytic triad of Asp-His-Ser in many serine proteases (with H₂O replacing the serine residue).

Binding Pocket

By encasing the nonpolar, four-carbon side-chain of the Lys residue on the ligand, Phe152 and Phe208 engage in hydrophobic Van der Waals with the ligand and at different ends of the , Trp141 and Met274 contribute to the overall shape through general hydrophobic interactions.^[4] Finally, the carbonyl oxygen of Gly151 hydrogen bonds with the amide hydrogen of the acetylated lysine to further interact with the ligand in the relatively hydrophobic tunnel.^[1]

At the rim of the active site, is involved in two hydrogen bonds between its own carbonyl oxygens and two consecutive amide hydrogens of incoming . This forces the ligand to assume a cis-conformation. In addition, extensive interactions among many other polar atoms near the rim of the active site help keep the ligand lodged in the hydrophobic tunnel.^[1]

Additional Features

(amino acid residues 30-36) lines a large part of one face of the active site pocket and extends to the protein surface. This results in a larger surface opening of the active site pocket. It is suggested that this loop has high flexibility that enables HDAC8 to more efficiently accommodate binding to a variety of different ligands. ^[3]

The activity of HDAC8 is regulated by phosphorylation at by protein kinase A(PKA) as the phosphorylation has been shown to decrease the enzyme’s activity.^[3] Ser39 lies at the surface of HDAC8, approximately 20Å from the opening to the HDAC8 active site so it is likely part of the surface that interacts with the target histone. The interaction between the HDAC8 and target histone could be disrupted by the phosphorylation of Ser39 because the phosphorylated Ser39 elicits a structural rearrangement that extends to the active site and thus disrupts enzyme activity. Ser39 elicits this rearrangement by interactions with structural elements in the conformational active loop L1, such as K36. Therefore, the Ser39 phosphorylation by PKA is likely inducing a conformational change of the L1 loop that prohibits a competent substrate binding.^[3]

Mechanism

Once the substrate is bound to the binding pocket through interactions with , the water molecule attacks the carbonyl carbon of the ε-amino-lysine sidechain of N-terminal core of histone proteins (Figure 3). This water molecule is recruited and stabilized by . The first dyad consists of His143 and Asp183. Asp183 interacts with His143 to shift electron density so that His143 may act as a general base to remove a proton from water. The second catalytic dyad consists of His142 and Asp176 and stabilizes the now deprotonated water molecule. A Zn²⁺ ion also makes the water more acidic making it a better nucleophile. The tetrahedral intermediate is stabilized by the Zn²⁺ ion as well as Tyr306. The amine group of the substrate's lysine acts as a general base and deprotonates His143. This drives the tetrahedral intermediate to collapse and expel the acetyl group to produce an acetate ion and a deacetylated lysine residue. ^[5]

Figure 3: HDAC8 Mechanism

Medical Relevance

Besides controlling gene regulation through deacetylation of histones, HDAC8 also regulates the post-transcriptional acetylation status of many non-histone proteins, including transcription factors, chaperones, hormone receptors and signaling molecules. Thus, it has influences on protein stability, protein-protein interactions and protein-DNA interactions. HDAC8 can therefore affect the regulation of cell proliferation and cell death. These processes are typically being altered in cancer cells and that makes HDAC enzymes an interesting potential target for cancer drugs. HDAC inhibitors have been shown to be promising cancer drug agent as the HDAC inhibitors (HDACi) cease tumor growth in cancer cells by either making them differentiate, undergo apoptosis or upregulate cell cycle arrest proteins. ^[6] One way the HDAC inhibitors cease tumor growth is by the reactivation of the transcription factor, RUNX3, a known tumor suppressor. HDACi increases the acetylation of the protein and as the stability of RUNX3 is dependent on the acetylation status of the protein, the increased acetylation or HDAC inhibition will enhance the protein stability. A number of HDAC inhibitors have been purified from natural sources or synthesized and at least four structurally different inhibitor classes have been characterized: hydroxamates, cyclic peptides, aliphatic acids and benzamides. The Vorinostat (within the hydroxamate class) has been FDA-approved for treatment of cancer. The hydroxamate HDAC inhibitors consists of a metal-binding domain, a linker domain and a hydrophobic capping group. The HDAC class 1 hydroxamic acid, compound 1, in a bidendate fashion while making hydrogen bonds to important residues as at the active site of HDAC8. Thus, the HDAC inhibitors can be used as antagonists to prevent the functioning of HDAC8 in cancer treatment. ^[7]